Product Image

Teen's Max Catch Minis

Carlson
4.9
★ ★ ★ ★ ★
(378 ratings)
Omega-3 1000 mg
EPA (Eicosapentaenoic Acid) 600 mg
DHA 400 mg
Marine oil (unspecified) 1250 mg
Product Image
Score73
A concentrated teen-oriented omega-3 with useful EPA and DHA in smaller softgels, though source-quality details and value are less compelling.
How scoring works
Quantity:60 Softgel(s) • (30 servings)
Goals:
Heart Health
Skin Health
Joint Health
Metabolism Boost
Vision Support

Score 73

A concentrated teen-oriented omega-3 with useful EPA and DHA in smaller softgels, though source-quality details and value are less compelling.
How scoring works
$31.92($1.06 per serving)
iHerb
$ 31.92
Report prices

Analysis

EPA and DHA are supplied in substantial amounts that can support heart, skin, vision, joint, and brain-related nutrition. The EPA-forward ratio is broad rather than specifically optimized for DHA-led cognitive or visual goals.

Total marine oil and each major omega-3 amount are clearly disclosed, showing strong concentration. The label does not identify triglyceride versus ethyl-ester form or provide oxidation markers, limiting assessment of absorption and freshness.

Teens who struggle with large fish-oil capsules may find the mini-softgel format helpful. A parent or clinician should consider diet, body size, medications, and total omega-3 intake rather than assuming the full adult-like serving fits every teen.

Who is it for
  • Teens who need supplemental EPA and DHA
  • Young users who prefer smaller flavored softgels
Best for
  • Broad teen omega-3 support
  • EPA-forward heart and skin nutrition

Pros

  • Meaningful EPA and DHA amounts
  • High omega-3 concentration
  • Mini-softgel format
  • Major fatty acids are disclosed separately

Cons

  • Molecular form is not stated
  • No oxidation-quality details
  • DHA is lower than EPA
  • High serving cost

Warnings

  • Fish-derived oil is unsuitable for teens with fish allergy
  • A parent or clinician should guide use with anticoagulant or antiplatelet medicines
  • Omega-3 softgels may cause reflux or fishy aftertaste
  • Do not add other high-dose omega-3 products without checking the combined intake

Nutrient quality

85 Highest impact

A substantial EPA-forward omega-3 amount provides meaningful depth for the intended uses. Missing molecular form, source, and oxidation-protection details limit quality confidence despite the focused formula.

Ingredient transparency

80 Highest impact

EPA and DHA have clear amounts, and no blend hides the key fatty-acid doses. Source, molecular-form, daily-direction, and inactive-ingredient details remain incomplete.

Customer satisfaction

69 High impact

The supplied aggregate rating is favorable and supported by a useful review volume. Detailed feedback is unavailable, so repeated complaints and fit with the intended use cannot be judged.

Value for money

51 Moderate impact

The formula provides weak practical value for its key fatty-acid content. The focused active profile preserves category competitiveness.

Report analysis

Goals

Heart Health
Heart Health
Impact
Highest effect
A+ Goal FitA- Strength of SupportB CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 600 mg

The clearly disclosed 600 mg EPA and 400 mg DHA provide strong support for triglyceride management and inflammatory balance. The EPA-forward profile is directly relevant to cardiovascular health and rests on substantial human evidence.

A full gram of identified omega-3 fatty acids gives this focused formula strong dose depth. The molecular form, oxidation protection, and contaminant-testing evidence are not provided, which limits quality assessment.

Study evidence
Skin Health
Skin Health
Impact
Highest effect
B Goal FitA- Strength of SupportB- CoverageA- Formula Quality
Omega-3 · 1000 mg

EPA and DHA provide substantial support for skin barrier lipids and inflammatory balance. Their individual amounts are clearly disclosed in a compact softgel serving.

The formula has good depth in one skin pathway but does not add collagen, hydration, or antioxidant cofactors. Molecular form and independent contaminant testing are not stated, which limits a full quality assessment.

Study evidence
Omega-3 Supportive 35 studies
Joint Health
Joint Health
Impact
High effect
B+ Goal FitB+ Strength of SupportD CoverageA+ Formula Quality
Omega-3 · 1000 mg

EPA and DHA directly target inflammatory pathways that can affect joint comfort. The serving provides 600 mg EPA and 400 mg DHA with clear individual disclosure.

The amount is meaningful for general anti-inflammatory support but does not provide cartilage building blocks or lubrication. Molecular form, source species, oxidation protection, and independent purity testing are not shown.

Study evidence
Omega-3 Supportive 40 studies
Metabolism Boost
Metabolism Boost
Impact
High effect
B- Goal FitA- Strength of SupportC CoverageA Formula Quality
Omega-3 · 1000 mg

EPA and DHA at 1,000 mg support cell membranes, inflammatory balance, and insulin signaling. Their effect on metabolic rate or fat loss is indirect rather than thermogenic.

The concentrated softgels clearly disclose EPA and DHA and provide a meaningful combined amount. The focused oil offers good depth without thyroid, thermogenic, or mitochondrial-energy cofactors.

Study evidence
Omega-3 Supportive 42 studies
Vision Support
Vision Support
Impact
High effect
B- Goal FitB Strength of SupportC CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 600 mg

DHA provides structural support for retinal cell membranes, while EPA contributes anti-inflammatory support. The formula does not include macular carotenoids or antioxidant vitamins and minerals.

The EPA and DHA amounts are substantial and clearly disclosed. Missing molecular-form, antioxidant, and contaminant-testing details limit confidence in oil quality.

Study evidence
Mental Focus
Mental Focus
Impact
Moderate effect
D Goal FitC Strength of SupportD CoverageB+ Formula Quality

EPA and DHA provide long-term structural and inflammatory support that may help create better conditions for concentration. Their connection to immediate attention is indirect and weaker than the evidence for stimulants or established nootropics.

The serving supplies substantial, separately disclosed omega-3 amounts. The oil form, oxidation protection, and independent contaminant testing are not stated.

Study evidence

Ingredients

IngredientAmount per serving
Calories
15 Calorie(s)
Total Fat
1.5 Gram(s)
Marine Oil concentrate
1250 mg
Total Omega-3 Fatty Acids
1000 mg
Eicosapentaenoic Acid
600 mg
Docosahexaenoic Acid
400 mg
Gluten Free Adults 18–50 Children 4+
Report overview
Omega-3 · 1000 mg OverallScore56
D- Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyD+ Value

The concentrated marine oil is treated as an ethyl-ester form and lacks a named fish source or antioxidant. EPA and DHA are separately disclosed at a very high concentration. Cost per active gram is average, while no independent purity certification is stated.

View ingredientView products
EPA (Eicosapentaenoic Acid) · 600 mg OverallScore51
D Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyF Value

A substantial EPA dose and EPA-forward balance align well with the collection. EPA is concentrated within the marine oil, although the molecular form and antioxidant protection are not disclosed. No contaminant-testing claim is provided, and the cost per gram of EPA is relatively high.

View ingredientView products
DHA · 400 mg OverallScore30
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

Two mini softgels provide a mid-range DHA dose from a highly concentrated marine oil. The chemical form, antioxidant system, fish species, and purity testing are not disclosed. Cost per DHA amount is high.

View ingredientView products
Loading alternative details
76 Performance

Maximum Omega Minis Natural Lemon Flavor

Carlson
A formulation advantage for the right user over Teen's Max Catch Minis is a substantial EPA-forward omega-3 amount in a focused mini-softgel formula. Molecular form, fish source, oxidation protection, and independent purity details are not supplied. The serving is not specifically designed for teens.
78 Performance

Children's DHA Strawberry

Nordic Naturals
A formulation advantage for the right user over Teen's Max Catch Minis is a moderate DHA-forward omega-3 serving in a child-focused strawberry formula. Fish source, molecular form, oxidation protection, and independent purity details are not supplied.
86 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
A formulation advantage for the right user over Teen's Max Catch Minis is a highly concentrated 1,100 mg triglyceride omega-3 serving with clear EPA and DHA amounts. Molecular distillation adds purity assurance, though fish species, antioxidant protection, and independent testing are not stated. The serving is not specifically designed for teens.
79 Budget

Fish Oil 1000 mg

Mason Natural
Lower recurring cost is the clearest advantage over Teen's Max Catch Minis, while the formula provides clearly disclosed EPA and DHA in a basic fish-oil softgel. The active omega-fat amount is low, and source, molecular form, oxidation protection, and purity testing are not supplied. The serving is not specifically designed for teens.
82 Budget

Omega 3 Fish Oil Concentrate

Solgar
Lower recurring cost is the clearest advantage over Teen's Max Catch Minis, while the formula provides a modest, clearly disclosed EPA and DHA serving for routine use. Low concentration plus missing molecular-form, source, oxidation, and purity details limit quality confidence. The serving is not specifically designed for teens.
69 Budget

Kid's Chewable DHA 100 mg Bursting Orange Flavor!

Carlson
Lower recurring cost is the clearest advantage over Teen's Max Catch Minis, while the formula provides triglyceride fish oil and vitamin E in a child-friendly chewable with 100 mg DHA. The active omega-3 amount and oil concentration are low, and independent purity testing is not supplied.
84 Value

Omega-3 Fish Oil 1250 mg

SR Sports Research
Lower recurring cost paired with a highly concentrated EPA-led fish-oil serving in one softgel creates a useful value trade-off versus Teen's Max Catch Minis. Molecular form, purification, antioxidant protection, fish species, and independent testing are not supplied. The serving is not specifically designed for teens.
84 Value

Fish Oil 1400 mg

Nature's Bounty
Lower recurring cost paired with a meaningful EPA-led amount with strong oil concentration creates a useful value trade-off versus Teen's Max Catch Minis. The ethyl-ester form is less readily absorbed, and fish source, antioxidant protection, and independent testing are not stated. The serving is not specifically designed for teens.
84 Value

Omega 3 Fish Oil Concentrate

Solgar
Lower recurring cost paired with triglyceride fish oil with individual fatty acids clearly disclosed creates a useful value trade-off versus Teen's Max Catch Minis. Active concentration is modest, while source, oxidation protection, and independent purity details are missing. The serving is not specifically designed for teens.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  2. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  3. Meta-analysis Comparing Combined Use of Eicosapentaenoic Acid and Statin to Statin Alone.
    Doshi R; Kumar A; Thakkar S; Shariff M; Adalja D; Doshi A; Taha M; Gupta R; Desai R; Shah J; Gullapalli N · The American journal of cardiology · 2020
    Meta-analysis27,415 participants5 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  4. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  5. Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease.
    Toyama K; Nishioka T; Isshiki A; Ando T; Inoue Y; Kirimura M; Kamiyama T; Sasaki O; Ito H; Maruyama Y; Yoshimoto N · Cardiovascular drugs and therapy · 2014
    Randomized trial80 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  6. Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome.
    Satoh N; Shimatsu A; Kotani K; Himeno A; Majima T; Yamada K; Suganami T; Ogawa Y · Hypertension research : official journal of the Japanese Society of Hypertension · 2010
    Randomized trial92 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  7. The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review.
    Innes JK; Calder PC · International journal of molecular sciences · 2018
    Systematic review527 participants6 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  8. Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids.
    Grimsgaard S; Bonaa KH; Hansen JB; Nordøy A · The American journal of clinical nutrition · 1997
    Randomized trial234 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  9. Effect of omega-3 long-chain polyunsaturated fatty acid supplementation on heart rate: a meta-analysis of randomized controlled trials.
    Hidayat K; Yang J; Zhang Z; Chen GC; Qin LQ; Eggersdorfer M; Zhang W · European journal of clinical nutrition · 2019
    Meta-analysis3,000 participants51 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  10. Long-Chain Polyunsaturated Fatty Acids Are Associated with Blood Pressure and Hypertension over 10-Years in Black South African Adults Undergoing Nutritional Transition.
    Zec MM; Schutte AE; Ricci C; Baumgartner J; Kruger IM; Smuts CM · Foods (Basel, Switzerland) · 2020
    Cohort study300 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  11. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  12. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  13. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  14. What did we learn in 35 years of research on nutrition and supplements for age-related macular degeneration: a systematic review.
    Pameijer EM; Heus P; Damen JAA; Spijker R; Hooft L; Ringens PJ; Imhof SM; van Leeuwen R · Acta ophthalmologica · 2023
    Systematic review27 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  15. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  16. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsVision Support forEPA (Eicosapentaenoic Acid)
  17. Association between fatty acid intake and age-related macular degeneration: a meta-analysis.
    Lee Y; Lee L; Zhang L; Zhou Q · Frontiers in nutrition · 2024
    Meta-analysisVision Support forEPA (Eicosapentaenoic Acid)
  18. Circulating omega-3 Fatty acids and neovascular age-related macular degeneration.
    Merle BM; Benlian P; Puche N; Bassols A; Delcourt C; Souied EH; Nutritional AMD Treatment 2 Study Group · Investigative ophthalmology & visual science · 2014
    Case-control study434 participantsVision Support forEPA (Eicosapentaenoic Acid)
  19. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  20. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  21. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  22. Dietary Intakes of Eicosapentaenoic Acid and Docosahexaenoic Acid and Risk of Age-Related Macular Degeneration.
    Wu J; Cho E; Giovannucci EL; Rosner BA; Sastry SM; Willett WC; Schaumberg DA · Ophthalmology · 2017
    Cohort study114,850 participantsVision Support forEPA (Eicosapentaenoic Acid)
  23. ASSOCIATION OF PLASMA ω-3 FATTY ACIDS WITH EARLY AGE-RELATED MACULAR DEGENERATION IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS.
    Karger AB; Guan W; Nomura SO; Weir NL; Klein BEK; Burke GL; Johnson WC; Tsai MY · Retina (Philadelphia, Pa.) · 2022
    Cohort study3,772 participantsVision Support forEPA (Eicosapentaenoic Acid)
  24. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  25. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  26. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  27. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  28. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  29. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  30. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  31. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  32. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  33. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  34. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  35. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  36. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  37. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  38. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  39. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  40. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3